Patient/advocate Diane Redington and Dr. Whitfield Growden discuss current scientific findings and clinical trials in ovarian and uterine carcinosarcoma. This is part three of a nine part series. Dr. Growden discusses how they have examined tumors (from Mass General’s tumor bank) of the fallopian tubes, ovary, uterus, and vagina. They found approximately 150 different mutations […]
Patient/advocate, Diane Redington and Dr. Michael Birrer discuss the results of GCS Project research to-date and where the research is headed. This is part two of a nine part series. Dr. Birrer discusses the fact that doctors typically treat ovarian carcinosarcoma the same as ovarian cancer, but they are NOT the same, and they should […]
Patient/advocate, Diane Redington and Dr. Michael Birrer discuss the results of GCS Project research to-date and where the research is headed. This is part one of a nine part series. Dr. Birrer states that they have already had initial results. They are doing what Dr. Birrer calls a “molecular deep dive” (sophisticated analysis) on a […]
An interview with Dr. Birrer who is leading the current research on MMMT through the Gynecologic Carcinosarcoma (GCS) Project. Tissue samples are needed.
An interview with Dr. Birrer and Diane Redington about the initial results of research being done on Gynecologic Carcinosarcoma at Mass General Hospital.